Home Diagnostics, a developer and manufacturer of blood glucose monitoring systems and disposable supplies for diabetics, registered for an initial public offering Monday evening. For the 2005 fiscal year, the company posted $100 million in product sales with a gross margin of 58.9%. JPMorgan and Piper Jaffray will be the joint book runners on the deal. Terms and timing have yet to be disclosed.
